American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3853)
  2. Hematologic Malignancies, Division of (3648)
  3. Center for Hematologic Malignancies (3549)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1292)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (938)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (900)
  10. Tow Center for Developmental Oncology (TCDO) (864)
Search Within
Formats
  1. Meeting Abstract (4152)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3853)
  2. Hematologic Malignancies, Division of (3648)
  3. Center for Hematologic Malignancies (3549)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1292)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (329)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (293)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (430)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5167)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5539)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in mice
    Journal Article

    Valerio, D. G.; Xu, H.; Eisold, M. E.; Woolthuis, C. M.; Pandita, T. K.; Armstrong, S. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
    Journal Article

    Döhner, H.; Estey, E.; Grimwade, D.; Amadori, S.; Appelbaum, F. R.; Büchner, T.; Dombret, H.; Ebert, B. L.; Fenaux, P.; Larson, R. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Crenolanib, a type I FLT3 TKI, can be safely combined with cytarabine and anthracycline induction chemotherapy and results in high response rates in patients with newly diagnosed FLT3 mutant acute myeloid leukemia (AML)
    Meeting Abstract

    Wang, E. S.; Stone, R. M.; Tallman, M. S.; Walter, R. B.; Eckardt, J. R.; Collins, R.
    Blood (2016)

    Fulltext@MSK | Save
  • CD97 is a critical regulator of acute myeloid leukemia stem cell function
    Meeting Abstract

    Martin, G. H.; Desrichard, A.; Chung, S. S.; Woolthuis, C.; Hu, W.; Garrett-Bakelman, F. E.; Hamann, J.; Chan, T.; Park, C. Y.
    Blood (2016)

    Fulltext@MSK | Save
  • Pembrolizumab in relapsed/refractory classical Hodgkin lymphoma: Primary end point analysis of the phase 2 keynote-087 study
    Meeting Abstract

    Moskowitz, C. H.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N. A.; Radford, J. A.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; Tomita, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Preliminary results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Herrera, A. F.; Bartlett, N. L.; Ramchandren, R.; Vose, J. M.; Moskowitz, A. J.; Feldman, T. A.; LaCasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact on outcomes of baseline bilirubin in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome receiving defibrotide treatment: A post-hoc analysis
    Meeting Abstract

    Richardson, P. G.; Smith, A. R.; Triplett, B. M.; Kernan, N. A.; Grupp, S. A.; Antin, J. H.; Lehmann, L.; Liang, W.; Hume, R.; Tappe, W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • High PRMT1 expression promotes the progression of acute megakaryocytic leukemia via controlling metabolic pathways
    Meeting Abstract

    Su, H.; Guo, H.; Tran, N. T.; Luo, M.; Zhao, X.
    Blood (2016)

    Fulltext@MSK | Save
  • A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult T-cell leukemia-lymphoma: Overall response rate, progression-free survival, and overall survival
    Meeting Abstract

    Phillips, A.; Fields, P.; Hermine, O.; Ramos, J. C.; Beltran, B. E.; Pereira, J.; Brites, C.; Wandroo, F. A.; Lill, M.; Feldman, T. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • miR-99 regulates normal and leukemic stem cell function
    Meeting Abstract

    Khalaj, M.; Woolthuis, C.; Hu, W. H.; Durham, B. H.; Park, C. Y.
    Blood (2016)

    Fulltext@MSK | Save